Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab-Reference-Cited by-同舟云学术

Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab

Published:2015-01-20 Issue:8 Volume:29 Page:1576-1581
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Bissonnette R.¹,Maari C.¹,Barber K.²,Lynde C.W.³,Vender R.⁴

Affiliation:

1. Innovaderm Research; Montreal QC Canada

2. Kirk Barber Research; Calgary AB Canada

3. Lynderm Research; Markham ON Canada

4. Dermatrials Research; Hamilton ON Canada

Funder

AbbVie

Amgen

Celgene

Eli-Lilly Galderma

Incyte

Janssen

Leo Pharma

Merck

Novartis

Pfizer

Tribute

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.12943/fullpdf

Reference13 articles.

1. Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial;Menter;J Am Acad Dermatol,2008

2. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction;Papp;Br J Dermatol,2005

3. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial;Reich;Lancet,2005

4. An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab;Vender;J Drugs Dermatol,2011

5. Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays;Vande Casteele;Aliment Pharmacol Ther,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of TNF-β in psoriasis and hidradenitis suppurativa;Italian Journal of Dermatology and Venereology;2022-08

2. Biologics switch in psoriasis;Immunotherapy;2019-04

3. Treatment response in patients with moderate-to-severe psoriasis who had inadequate response to prior secukinumab;Dermatologica Sinica;2019

4. A Review of Switching Biologic Agents in the Treatment of Moderate-to-Severe Plaque Psoriasis;Clinical Drug Investigation;2017-12-16

5. Systematic review of efficacy of anti–tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti–TNF agent;Journal of the American Academy of Dermatology;2016-09